Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop

F. Cricchi, C. Di Lorenzo, G. S. Grieco, C. Rengo, A. Cardinale, M. Racaniello, F. M. Santorelli, G. Nappi, F. Pierelli, C. Casali

Research output: Contribution to journalArticle

Abstract

Familial hemiplegic migraine type 1, spinocerebellar ataxia type 6 (SCA6) and episodic ataxia type 2 (EA2) are allelic disorders associated with mutations in the CACNA1A gene, which encodes the α1 subunit of the P/Q-type calcium channel (CaV2.1). SCA6 and EA2 share a number of clinical features, such as prominent cerebellar involvement and good response to acetazolamide therapy. However, while SCA6 develops as a late-onset, progressive ataxia, EA2 has an earlier, and episodic, onset. We report on two sisters with a heterogeneous clinical phenotype. The first developed progressive cerebellar ataxia after age 30, without noticeable episodes of vertigo or headache. A 1 year trial with acetazolamide did not produce significant results. The other reported episodes of vertigo, headache and gait imbalance since late childhood, with good response to acetazolamide, before developing moderate chronic cerebellar ataxia. Brain MRI showed cerebellar atrophy, especially in the vermis, in both patients. Direct sequencing of CACNA1A identified a heterozygous 1360G>A mutation in exon 11 resulting in the substitution of alanine for threonine at residue 454 (p.Ala454Thr). This is the first description of a change residing in the cytoplasmic I-II loop associated with a clinical phenotype.

Original languageEnglish
Pages (from-to)69-71
Number of pages3
JournalJournal of the Neurological Sciences
Volume254
Issue number1-2
DOIs
Publication statusPublished - Mar 15 2007

Fingerprint

Spinocerebellar Ataxias
Acetazolamide
Ataxia
Cerebellar Ataxia
Vertigo
Mutation
Headache
Q-Type Calcium Channels
P-Type Calcium Channels
Phenotype
Threonine
Gait
Alanine
Atrophy
Siblings
Exons
Brain
Genes
Type 2 Episodic Ataxia
Type 6 Episodic Ataxia

Keywords

  • Ataxia
  • CACNA1A
  • EA2
  • I-II loop
  • SCA6

ASJC Scopus subject areas

  • Ageing
  • Clinical Neurology
  • Surgery
  • Developmental Neuroscience
  • Neurology
  • Neuroscience(all)

Cite this

Cricchi, F., Di Lorenzo, C., Grieco, G. S., Rengo, C., Cardinale, A., Racaniello, M., ... Casali, C. (2007). Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop. Journal of the Neurological Sciences, 254(1-2), 69-71. https://doi.org/10.1016/j.jns.2007.01.008

Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop. / Cricchi, F.; Di Lorenzo, C.; Grieco, G. S.; Rengo, C.; Cardinale, A.; Racaniello, M.; Santorelli, F. M.; Nappi, G.; Pierelli, F.; Casali, C.

In: Journal of the Neurological Sciences, Vol. 254, No. 1-2, 15.03.2007, p. 69-71.

Research output: Contribution to journalArticle

Cricchi, F, Di Lorenzo, C, Grieco, GS, Rengo, C, Cardinale, A, Racaniello, M, Santorelli, FM, Nappi, G, Pierelli, F & Casali, C 2007, 'Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop', Journal of the Neurological Sciences, vol. 254, no. 1-2, pp. 69-71. https://doi.org/10.1016/j.jns.2007.01.008
Cricchi, F. ; Di Lorenzo, C. ; Grieco, G. S. ; Rengo, C. ; Cardinale, A. ; Racaniello, M. ; Santorelli, F. M. ; Nappi, G. ; Pierelli, F. ; Casali, C. / Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop. In: Journal of the Neurological Sciences. 2007 ; Vol. 254, No. 1-2. pp. 69-71.
@article{f594d534ba98467fb34d9ad0d2e9229f,
title = "Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop",
abstract = "Familial hemiplegic migraine type 1, spinocerebellar ataxia type 6 (SCA6) and episodic ataxia type 2 (EA2) are allelic disorders associated with mutations in the CACNA1A gene, which encodes the α1 subunit of the P/Q-type calcium channel (CaV2.1). SCA6 and EA2 share a number of clinical features, such as prominent cerebellar involvement and good response to acetazolamide therapy. However, while SCA6 develops as a late-onset, progressive ataxia, EA2 has an earlier, and episodic, onset. We report on two sisters with a heterogeneous clinical phenotype. The first developed progressive cerebellar ataxia after age 30, without noticeable episodes of vertigo or headache. A 1 year trial with acetazolamide did not produce significant results. The other reported episodes of vertigo, headache and gait imbalance since late childhood, with good response to acetazolamide, before developing moderate chronic cerebellar ataxia. Brain MRI showed cerebellar atrophy, especially in the vermis, in both patients. Direct sequencing of CACNA1A identified a heterozygous 1360G>A mutation in exon 11 resulting in the substitution of alanine for threonine at residue 454 (p.Ala454Thr). This is the first description of a change residing in the cytoplasmic I-II loop associated with a clinical phenotype.",
keywords = "Ataxia, CACNA1A, EA2, I-II loop, SCA6",
author = "F. Cricchi and {Di Lorenzo}, C. and Grieco, {G. S.} and C. Rengo and A. Cardinale and M. Racaniello and Santorelli, {F. M.} and G. Nappi and F. Pierelli and C. Casali",
year = "2007",
month = "3",
day = "15",
doi = "10.1016/j.jns.2007.01.008",
language = "English",
volume = "254",
pages = "69--71",
journal = "Journal of the Neurological Sciences",
issn = "0022-510X",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Early-onset progressive ataxia associated with the first CACNA1A mutation identified within the I-II loop

AU - Cricchi, F.

AU - Di Lorenzo, C.

AU - Grieco, G. S.

AU - Rengo, C.

AU - Cardinale, A.

AU - Racaniello, M.

AU - Santorelli, F. M.

AU - Nappi, G.

AU - Pierelli, F.

AU - Casali, C.

PY - 2007/3/15

Y1 - 2007/3/15

N2 - Familial hemiplegic migraine type 1, spinocerebellar ataxia type 6 (SCA6) and episodic ataxia type 2 (EA2) are allelic disorders associated with mutations in the CACNA1A gene, which encodes the α1 subunit of the P/Q-type calcium channel (CaV2.1). SCA6 and EA2 share a number of clinical features, such as prominent cerebellar involvement and good response to acetazolamide therapy. However, while SCA6 develops as a late-onset, progressive ataxia, EA2 has an earlier, and episodic, onset. We report on two sisters with a heterogeneous clinical phenotype. The first developed progressive cerebellar ataxia after age 30, without noticeable episodes of vertigo or headache. A 1 year trial with acetazolamide did not produce significant results. The other reported episodes of vertigo, headache and gait imbalance since late childhood, with good response to acetazolamide, before developing moderate chronic cerebellar ataxia. Brain MRI showed cerebellar atrophy, especially in the vermis, in both patients. Direct sequencing of CACNA1A identified a heterozygous 1360G>A mutation in exon 11 resulting in the substitution of alanine for threonine at residue 454 (p.Ala454Thr). This is the first description of a change residing in the cytoplasmic I-II loop associated with a clinical phenotype.

AB - Familial hemiplegic migraine type 1, spinocerebellar ataxia type 6 (SCA6) and episodic ataxia type 2 (EA2) are allelic disorders associated with mutations in the CACNA1A gene, which encodes the α1 subunit of the P/Q-type calcium channel (CaV2.1). SCA6 and EA2 share a number of clinical features, such as prominent cerebellar involvement and good response to acetazolamide therapy. However, while SCA6 develops as a late-onset, progressive ataxia, EA2 has an earlier, and episodic, onset. We report on two sisters with a heterogeneous clinical phenotype. The first developed progressive cerebellar ataxia after age 30, without noticeable episodes of vertigo or headache. A 1 year trial with acetazolamide did not produce significant results. The other reported episodes of vertigo, headache and gait imbalance since late childhood, with good response to acetazolamide, before developing moderate chronic cerebellar ataxia. Brain MRI showed cerebellar atrophy, especially in the vermis, in both patients. Direct sequencing of CACNA1A identified a heterozygous 1360G>A mutation in exon 11 resulting in the substitution of alanine for threonine at residue 454 (p.Ala454Thr). This is the first description of a change residing in the cytoplasmic I-II loop associated with a clinical phenotype.

KW - Ataxia

KW - CACNA1A

KW - EA2

KW - I-II loop

KW - SCA6

UR - http://www.scopus.com/inward/record.url?scp=33847277770&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33847277770&partnerID=8YFLogxK

U2 - 10.1016/j.jns.2007.01.008

DO - 10.1016/j.jns.2007.01.008

M3 - Article

C2 - 17292920

AN - SCOPUS:33847277770

VL - 254

SP - 69

EP - 71

JO - Journal of the Neurological Sciences

JF - Journal of the Neurological Sciences

SN - 0022-510X

IS - 1-2

ER -